Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision

Current test performance characteristics of blood-based colorectal cancer screening tests are insufficient to justify their high costs compared with less expensive and more effective alternatives such as fecal immunochemical testing, triennial stool DNA testing combined with a fecal immunochemical testing assay, and colonoscopy.

Source: Gastroenterology - March 26, 2024 Category: Gastroenterology Authors: Rosita van den Puttelaar, Pedro Nascimento de Lima, Amy B. Knudsen, Carolyn M. Rutter, Karen M. Kuntz, Lucie de Jonge, Fernando Alarid Escudero, David Lieberman, Ann G. Zauber, Anne I. Hahn, John M. Inadomi, Iris Lansdorp-Vogelaar Tags: Clinical - Alimentary Tract Source Type: research